Snyder RA - Search Results

1

Trends in the use of evidence-based therapy for resectable gastric cancer.

Snyder RA, Penson DF, Ni S, Koyama T, Merchant NB. Snyder RA, et al. J Surg Oncol. 2014 Sep;110(3):285-90. doi: 10.1002/jso.23635. Epub 2014 May 30. J Surg Oncol. 2014. PMID: 24891231 Free PMC article.

2

Gastric schwannoma.

Snyder RA, Harris E, Hansen EN, Merchant NB, Parikh AA. Snyder RA, et al. Am Surg. 2008 Aug;74(8):753-6. Am Surg. 2008. PMID: 18705581 Free article. No abstract available.

3

Granulocyte colony stimulating factor secreting hepatocellular carcinoma.

Snyder RA, Liu E, Merchant NB. Snyder RA, et al. Am Surg. 2012 Jul;78(7):821-2. Am Surg. 2012. PMID: 22748547 No abstract available.

4

Quality of colorectal cancer care among veterans: a 10-year retrospective cohort.

Snyder RA, Mainthia R, Patel R, Dittus RS, Roumie CL. Snyder RA, et al. Ann Surg Oncol. 2014 Aug;21(8):2476-83. doi: 10.1245/s10434-014-3689-3. Epub 2014 Apr 21. Ann Surg Oncol. 2014. PMID: 24748162

5

Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer.

Helmink BA, Snyder RA, Idrees K, Merchant NB, Parikh AA. Helmink BA, et al. Among authors: snyder ra. Surg Oncol Clin N Am. 2016 Apr;25(2):287-310. doi: 10.1016/j.soc.2015.11.008. Epub 2016 Feb 17. Surg Oncol Clin N Am. 2016. PMID: 27013365 Free PMC article. Review.

6

Thirty-day complication rates do not differ by race among patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.

Mitsakos AT, Dennis SO, Parikh AA, Snyder RA. Mitsakos AT, et al. Among authors: snyder ra. J Surg Oncol. 2021 Mar;123(4):970-977. doi: 10.1002/jso.26383. Epub 2021 Jan 26. J Surg Oncol. 2021. PMID: 33497474

7

Pancreas cancer trials for early stage disease: Surgeons leading therapeutic cooperative group trials.

Snyder RA, Ahmad S, Katz MHG. Snyder RA, et al. J Surg Oncol. 2022 Jan;125(1):75-83. doi: 10.1002/jso.26701. Epub 2021 Sep 29. J Surg Oncol. 2022. PMID: 34586635

8

Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer.

Hao S, Mitsakos A, Irish W, Tuttle-Newhall JE, Parikh AA, Snyder RA. Hao S, et al. Among authors: snyder ra. J Surg Oncol. 2022 Aug;126(2):302-313. doi: 10.1002/jso.26859. Epub 2022 Mar 22. J Surg Oncol. 2022. PMID: 35315932 Free PMC article.

9

Differential effects of the Affordable Care Act on the stage at presentation and receipt of treatment for pancreatic adenocarcinoma.

Hao S, Mitsakos A, Popowicz P, Irish W, Snyder RA, Parikh AA. Hao S, et al. Among authors: snyder ra. J Surg Oncol. 2022 Sep;126(4):698-707. doi: 10.1002/jso.26984. Epub 2022 Jun 14. J Surg Oncol. 2022. PMID: 35699593

10

Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.

Ogobuiro I, Collier AL, Khan K, de Castro Silva I, Kwon D, Wilson GC, Schwartz PB, Parikh AA, Hammill C, Kim HJ, Kooby DA, Abbott D, Maithel SK, Snyder RA, Ahmad SA, Merchant NB, Datta J. Ogobuiro I, et al. Among authors: snyder ra. Ann Surg Oncol. 2023 Mar;30(3):1485-1494. doi: 10.1245/s10434-022-12741-4. Epub 2022 Oct 31. Ann Surg Oncol. 2023. PMID: 36316508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page